BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 35406628)

  • 1. Determination of T-cell clonality and expression profiles of Toll-like receptors signaling pathway genes and related miRNAs in patients with mycosis fungoides.
    Seçme M; Dodurga Y; Demirkan NÇ; Kaçar N; Günel NS; Açıkbaş İ
    Gene; 2024 Jan; 891():147825. PubMed ID: 37748629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D in Cutaneous T-Cell Lymphoma.
    Ødum AF; Geisler C
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis.
    Gaydosik AM; Stonesifer CJ; Tabib T; Lafyatis R; Geskin LJ; Fuschiotti P
    JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37669110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of serum and tissue level of interleukin-15 (IL-15) and IL-15 receptor alpha (IL-15Rα) in mycosis fungoides before and after phototherapy: An interventional cohort study.
    Mogawer RM; Youssef R; Helmy K; Emad N; Shaker O; Orabi S
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12938. PubMed ID: 38157308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, tropism, and activity of cutavirus in circulating blood lymphocytes, stool, and skin biopsy specimens of patients with cutaneous T-cell lymphoma and parapsoriasis en plaques.
    Mohanraj U; Väkevä L; Ranki A; Söderlund-Venermo M
    J Med Virol; 2024 Apr; 96(4):e29575. PubMed ID: 38549497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-related increase in PIM2 expression in mycosis fungoides.
    Nielsen MH; Nielsen PR; Bzorek M; Eriksen JO; Wehkamp U; Lindahl LM; Woetmann A; Ødum N; Litman T; Gjerdrum LMR
    APMIS; 2024 May; ():. PubMed ID: 38757234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant T Cell Activation by a
    Dehner CA; Ruff WE; Greiling T; Pereira MS; Redanz S; McNiff J; Girardi M; Kriegel MA
    JID Innov; 2022 Mar; 2(2):100084. PubMed ID: 35199089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Null T-cell phenotype mycosis fungoides with aberrant CD20 and CD56 expression: A diagnostic dilemma.
    Aran BM; Burton R; High WA; Gru AA
    J Cutan Pathol; 2024 May; ():. PubMed ID: 38725374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic heterogeneity of mycosis fungoides cells leads to the difficulties in determining tumour origin.
    Jin S; Zhao Y; Wang S; Wang P; Tang C; Zhu M; Wang P
    Australas J Dermatol; 2024 May; ():. PubMed ID: 38726851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Evidence Linking Interleukin-22 Tissue Expression Levels to FOXP3+ Cells and Neutrophil Densities in the Mycosis Fungoides Microenvironment.
    Syrnioti A; Georgiou E; Patsatsi A; Dimitriadis D; Papathemeli D; Koletsa T
    Cureus; 2023 Sep; 15(9):e46085. PubMed ID: 37900389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Dimensional Mass Cytometry Reveals Emphysema-associated Changes in the Pulmonary Immune System.
    Jia L; Li N; Abdelaal TRM; Guo N; IJsselstein ME; van Unen V; Lindelauf C; Jiang Q; Xiao Y; Pascutti MF; Hiemstra PS; Koning F; Stolk J; Khedoe PPSJ
    Am J Respir Crit Care Med; 2024 Mar; ():. PubMed ID: 38536165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waxy papules, infiltrated alopecic plaques, and shin ichthyosis.
    Bhat K; Madhudiya R; Elhence PA; Singh S
    Int J Dermatol; 2024 Mar; ():. PubMed ID: 38501702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology.
    Glasson Y; Chépeaux LA; Dumé AS; Lafont V; Faget J; Bonnefoy N; Michaud HA
    Semin Immunopathol; 2023 Jan; 45(1):17-28. PubMed ID: 36598557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Cytometric Analysis of Early-Stage Mycosis Fungoides.
    Guo N; Jia L; Out-Luiting C; Miranda NFCC; Willemze R; Koning F; Vermeer M; Quint K
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
    Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
    Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
    Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
    J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.